van der Gaast A, Alexieva-Figusch J, Vecht C, Verweij J, Stoter G
Department of Medical Oncology, University Hospital Rotterdam-Dijkzigt, Rotterdam, The Netherlands.
Am J Clin Oncol. 1990 Dec;13(6):507-9. doi: 10.1097/00000421-199012000-00011.
The prognosis of patients with brain metastases from breast cancer is poor. Median survival after radiotherapy is 5-6 months. We report a patient in whom a complete response of a brain metastasis was induced by megestrol acetate at a daily dose of 160 mg orally.
乳腺癌脑转移患者的预后较差。放疗后的中位生存期为5 - 6个月。我们报告了一例患者,口服醋酸甲地孕酮,每日剂量160毫克,其脑转移灶出现完全缓解。